Neuroprotective Effects of Statins: Evidence from Preclinical and Clinical Studies
Authors:
- 24 February 2012
- journal article
- Published by Springer Nature in Current Treatment Options in Cardiovascular Medicine
- Vol. 14 (3) , 252-259
Abstract
The benefits of statins for both primary and secondary prevention of ischemic stroke are clearly established. Evidence is accumulating that statin withdrawal after ischemic stroke may lead to worse outcome and that initiation of statins after ischemic stroke may reduce mortality and improve outcome. Current treatment guidelines recommend starting statins before discharge in patients with stroke related to atherosclerosis or who have elevated cholesterol. The primary treatment question then is not if to start statins in most ischemic stroke patients, but when. Our recommendation would be start a statin as soon as the patient passes a dysphagia screen and can safely take oral medication. Based on the results of the Heart Protection Study and the SPARCL trial, either simvastatin 40 mg or atorvastatin 80 mg are appropriate alternatives. Clinical trials are needed to demonstrate unequivocal efficacy of improved outcome and to determine if lower doses may have this effect. Additionally, improved outcome needs to be established in cardioembolic stroke patients before routine use of statins in this stroke subtype can be recommended.Keywords
This publication has 46 references indexed in Scilit:
- Statin Treatment and Functional Outcome After Ischemic StrokeStroke, 2011
- Preexisting Statin Use Is Associated With Greater Reperfusion in Hyperacute Ischemic StrokeStroke, 2011
- Association Between Acute Statin Therapy, Survival, and Improved Functional Outcome After Ischemic StrokeStroke, 2011
- Atorvastatin Extends the Therapeutic Window for tPA to 6 h after the Onset of Embolic Stroke in RatsJournal of Cerebral Blood Flow & Metabolism, 2009
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive ProteinNew England Journal of Medicine, 2008
- Intravenous Rosuvastatin for Acute Stroke TreatmentStroke, 2008
- Statin enhancement of collateralization in acute strokeNeurology, 2007
- HMG-CoA Reductase Inhibitors Improve Acute Ischemic Stroke OutcomeStroke, 2005
- Atorvastatin Upregulates Type III Nitric Oxide Synthase in Thrombocytes, Decreases Platelet Activation, and Protects From Cerebral Ischemia in Normocholesterolemic MiceStroke, 2000
- Neuroprotection mediated by changes in the endothelial actin cytoskeletonJournal of Clinical Investigation, 2000